☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
TYSABRI
Biogen Requests a Preliminary Injunction in BPCIA Case Against Sandoz Proposed Biosimilar of Tysabri (natalizumab)
October 27, 2022
PharmaShots Interview: Biogen’s Monica Mann Shares Insights on the New Real-World Data on Tysabri & Vumerity for the Treatment of...
May 17, 2022
Load more...
Back to Home
